Hints and tips:
...Smith & Nephew had given a “compelling rationale” for paying more to its US-based leaders, Glass Lewis said....
...Smith & Nephew’s share price is down 8.3 per cent over the past 12 months and is up 1.6 per cent this year....
...Proposed pay increases for executives at companies with large international operations such as the London Stock Exchange Group and medical devices manufacturer Smith & Nephew have sparked debate among investors...
...Meanwhile, medical devices company Smith & Nephew wants to increase pay for its US executives to bring it closer to American levels....
...Smith & Nephew survived a major shareholder revolt over a $2.6mn potential pay rise for its chief executive, in the latest controversy on executive remuneration by UK-listed companies competing with high-paying...
...Wednesday’s vote coincided with Smith & Nephew’s results for the first quarter of 2024....
...Both uncle and nephew are also in the running for selection for the Paris Olympics. For Jack, it would be his first Games, for John, his seventh....
...Big share price moves in Europe today include Spanish banks Banco de Sabadell and BBVA, and UK medical technology company Smith & Nephew: BBVA: Shares in the Spanish bank dropped 8 per cent, after Tuesday...
...London Stock Exchange Group and Smith & Nephew are among the FTSE 100 companies hoping to follow AstraZeneca by pushing through pay increases for their executives at upcoming annual meetings....
...Corporate results: Aston Martin Lagonda, Computacenter, GSK, Haleon, Next and Smith & Nephew will post results....
...Beyond a handful of genuinely transatlantic companies based in the UK with American nationals as CEOs, such as Smith & Nephew — again which you regularly cite — the market recruitment and retention arguments...
...Medical device maker Smith & Nephew lost then-chief executive Namal Nawana in 2019 because he wanted more pay, and has run through four CEOs in five years....
...Soames, chair of medical technology firm Smith & Nephew, will take over from Brian McBride, who has led the CBI through a tumultuous year during which a significant number of large companies cut ties with...
...Danone’s Chechen takeover: When a warlord’s nephew seized control of the French dairy group’s Russian operations, there was fear among staff of the company’s fate....
...& Nephew AGM and trading update, YUM!...
...Meanwhile, Smith & Nephew is one that is trying a new structure to bridge differentials in pay and related governance between the two markets....
...Smith & Nephew has warned that chip shortages are still hitting the medical device maker’s sales of surgical robotic technology and wound-protecting products, even as supply recovers at major chipmakers....
...For the 2023 financial year, Smith & Nephew is targeting revenue growth and trading profit margins above last year’s levels....
...Soames, chair of medical technology group Smith & Nephew, will take over from Brian McBride, who has led the CBI through a tumultuous year during which a significant number of large companies cut ties with...
...The former chief executive of outsourcing group Serco, and current chair of healthcare business Smith & Nephew, said the CBI still had an important role as a conduit between business and politicians....
...A trip to Paris, aged 20, led to a fortuitous encounter with Hubert de Givenchy, nephew of the celebrated fashion designer, who shares the same name....
...Results: Adecco, Adidas, Anheuser-Busch InBev, AXA, ING, London Stock Exchange, Lufthansa, Rolls-Royce, Serco, Smith & Nephew, Societe Generale and Veolia are among companies due to release results....
...Kennedy, who is the son of the late Senator Robert Kennedy and nephew of the former president John F Kennedy, is known for his scepticism towards vaccines and his questioning of the US’s support for Ukraine...
...Smith & Nephew Associated Co’s. Standard Chartered Bank Sun Alliance & London Insurance (RSA Insurance) Tesco Unilever Whitbread & Co....
...A notable example from 2019 was Namal Nawana’s decision to quit Smith & Nephew after 18 months because the UK medical devices company could not meet his pay demands....
International Edition